<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1998 (8) TMI 152 - CEGAT, CALCUTTA</title>
    <link>https://www.taxtmi.com/caselaws?id=88691</link>
    <description>Assessable value of patent or proprietary medicines cleared in wholesale trade had to be determined under section 4(1)(a) on the basis of the normal wholesale price at the time and place of removal, where the statutory conditions were satisfied. Notification No. 245/83, issued as an exemption under Rule 8(1), did not alter the statutory valuation scheme and could not be compelled on an assessee, especially where it would produce a higher duty burden. In the absence of retail sales by the manufacturer and without any wholesale price fixed under the Drugs (Prices Control) Order, the retail price under that order could not displace wholesale valuation. The assessee&#039;s valuation under section 4(1)(a) was upheld.</description>
    <language>en-us</language>
    <pubDate>Wed, 05 Aug 1998 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 20 Sep 2011 16:01:48 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=125756" rel="self" type="application/rss+xml"/>
    <item>
      <title>1998 (8) TMI 152 - CEGAT, CALCUTTA</title>
      <link>https://www.taxtmi.com/caselaws?id=88691</link>
      <description>Assessable value of patent or proprietary medicines cleared in wholesale trade had to be determined under section 4(1)(a) on the basis of the normal wholesale price at the time and place of removal, where the statutory conditions were satisfied. Notification No. 245/83, issued as an exemption under Rule 8(1), did not alter the statutory valuation scheme and could not be compelled on an assessee, especially where it would produce a higher duty burden. In the absence of retail sales by the manufacturer and without any wholesale price fixed under the Drugs (Prices Control) Order, the retail price under that order could not displace wholesale valuation. The assessee&#039;s valuation under section 4(1)(a) was upheld.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Wed, 05 Aug 1998 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=88691</guid>
    </item>
  </channel>
</rss>